Search research articles
Contact Us
Filters
Showing results (31-40 of 51) with videos related to
Page
of 6
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN
|
January 12, 2024
Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial
Jonathan Barratt, Adrian Liew, See Cheng Yeo, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
August 21, 2007
Clinical trial to evaluate omega-3 fatty acids and alternate day prednisone in patients with IgA nephropathy: report from the Southwest Pediatric Nephrology Study Group
Ronald J Hogg, Jeannette Lee, Nancy Nardelli, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
December 5, 2017
X-Linked Glomerulopathy Due to COL4A5 Founder Variant
Moumita Barua, Rohan John, Lorenzo Stella, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
July 26, 2015
Randomized controlled trial of mycophenolate mofetil in children, adolescents, and adults with IgA nephropathy
Ronald J Hogg, R Curtis Bay, J Charles Jennette, et al.
Nephron
|
March 7, 2021
Association of Obesity with Cardiovascular Risk Factors and Kidney Disease Outcomes in Primary Proteinuric Glomerulopathies
Paras P Shah, Tammy M Brady, Kevin E C Meyers, et al.
American Journal of Physiology. Renal Physiology
|
November 17, 2017
Dapagliflozin in focal segmental glomerulosclerosis: a combined human-rodent pilot study
Harindra Rajasekeran, Heather N Reich, Michelle A Hladunewich, et al.
The Lancet. Diabetes & Endocrinology
|
June 20, 2020
Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial
David Z I Cherney, Claire C J Dekkers, Sean J Barbour, et al.
Journal of the American Society of Nephrology : JASN
|
September 11, 2016
A Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy
Mark Haas, Jacobien C Verhave, Zhi-Hong Liu, et al.
Nephron
|
November 21, 2015
Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy
John Feehally, Rosanna Coppo, Stéphan Troyanov, et al.
JAMA
|
August 2, 2017
Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial
Jicheng Lv, Hong Zhang, Muh Geot Wong, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 51) with videos related to
Sort By:
Page
of 6
Clinical Journal of the American Society of Nephrology : CJASN
|
January 12, 2024
Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial
Jonathan Barratt, Adrian Liew, See Cheng Yeo, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
August 21, 2007
Clinical trial to evaluate omega-3 fatty acids and alternate day prednisone in patients with IgA nephropathy: report from the Southwest Pediatric Nephrology Study Group
Ronald J Hogg, Jeannette Lee, Nancy Nardelli, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
December 5, 2017
X-Linked Glomerulopathy Due to COL4A5 Founder Variant
Moumita Barua, Rohan John, Lorenzo Stella, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
July 26, 2015
Randomized controlled trial of mycophenolate mofetil in children, adolescents, and adults with IgA nephropathy
Ronald J Hogg, R Curtis Bay, J Charles Jennette, et al.
Nephron
|
March 7, 2021
Association of Obesity with Cardiovascular Risk Factors and Kidney Disease Outcomes in Primary Proteinuric Glomerulopathies
Paras P Shah, Tammy M Brady, Kevin E C Meyers, et al.
American Journal of Physiology. Renal Physiology
|
November 17, 2017
Dapagliflozin in focal segmental glomerulosclerosis: a combined human-rodent pilot study
Harindra Rajasekeran, Heather N Reich, Michelle A Hladunewich, et al.
The Lancet. Diabetes & Endocrinology
|
June 20, 2020
Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial
David Z I Cherney, Claire C J Dekkers, Sean J Barbour, et al.
Journal of the American Society of Nephrology : JASN
|
September 11, 2016
A Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy
Mark Haas, Jacobien C Verhave, Zhi-Hong Liu, et al.
Nephron
|
November 21, 2015
Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy
John Feehally, Rosanna Coppo, Stéphan Troyanov, et al.
JAMA
|
August 2, 2017
Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial
Jicheng Lv, Hong Zhang, Muh Geot Wong, et al.
Page
of 6